Spaces:
Running
Running
Upload 161 files
Browse filesThis view is limited to 50 files because it contains too many changes. Β
See raw diff
- README.md +16 -11
- app.py +57 -28
- backend/chat_endpoint.py +41 -0
- backend/pdf_utils.py +24 -12
- backend/rag_engine.py +42 -31
- backend/soap_generator.py +20 -11
- data/guidelines/internal_med/001_Thyroid_Dysfunction.txt +34 -0
- data/guidelines/internal_med/002_COPD_Exacerbation.txt +34 -0
- data/guidelines/internal_med/003_Anemia.txt +34 -0
- data/guidelines/internal_med/004_UTI.txt +34 -0
- data/guidelines/internal_med/005_Hypertension.txt +34 -0
- data/guidelines/internal_med/006_Thyroid_Dysfunction.txt +34 -0
- data/guidelines/internal_med/007_UTI.txt +34 -0
- data/guidelines/internal_med/008_Diabetes_Mellitus.txt +34 -0
- data/guidelines/internal_med/009_Anemia.txt +34 -0
- data/guidelines/internal_med/010_Hypertension.txt +34 -0
- data/guidelines/internal_med/011_AKI.txt +34 -0
- data/guidelines/internal_med/012_UTI.txt +34 -0
- data/guidelines/internal_med/013_Hypertension.txt +34 -0
- data/guidelines/internal_med/014_COPD_Exacerbation.txt +34 -0
- data/guidelines/internal_med/015_Hypertension.txt +34 -0
- data/guidelines/internal_med/016_Anemia.txt +34 -0
- data/guidelines/internal_med/017_Chest_Pain.txt +34 -0
- data/guidelines/internal_med/018_Diabetes_Mellitus.txt +34 -0
- data/guidelines/internal_med/019_Asthma.txt +34 -0
- data/guidelines/internal_med/020_Asthma.txt +34 -0
- data/guidelines/internal_med/021_Anemia.txt +34 -0
- data/guidelines/internal_med/022_Hypertension.txt +34 -0
- data/guidelines/internal_med/023_Fever_of_Unknown_Origin.txt +34 -0
- data/guidelines/internal_med/024_Chest_Pain.txt +34 -0
- data/guidelines/internal_med/025_UTI.txt +34 -0
- data/guidelines/internal_med/026_AKI.txt +34 -0
- data/guidelines/internal_med/027_Anemia.txt +34 -0
- data/guidelines/internal_med/028_Asthma.txt +34 -0
- data/guidelines/internal_med/029_Diabetes_Mellitus.txt +34 -0
- data/guidelines/internal_med/030_Hypertension.txt +34 -0
- data/guidelines/internal_med/031_Anemia.txt +34 -0
- data/guidelines/internal_med/032_Chest_Pain.txt +34 -0
- data/guidelines/internal_med/033_Fever_of_Unknown_Origin.txt +34 -0
- data/guidelines/internal_med/034_COPD_Exacerbation.txt +34 -0
- data/guidelines/internal_med/035_Chest_Pain.txt +34 -0
- data/guidelines/internal_med/036_COPD_Exacerbation.txt +34 -0
- data/guidelines/internal_med/037_Fever_of_Unknown_Origin.txt +34 -0
- data/guidelines/internal_med/038_AKI.txt +34 -0
- data/guidelines/internal_med/039_Fever_of_Unknown_Origin.txt +34 -0
- data/guidelines/internal_med/040_UTI.txt +34 -0
- data/guidelines/internal_med/041_Fever_of_Unknown_Origin.txt +34 -0
- data/guidelines/internal_med/042_AKI.txt +34 -0
- data/guidelines/internal_med/043_Thyroid_Dysfunction.txt +34 -0
- data/guidelines/internal_med/044_Fever_of_Unknown_Origin.txt +34 -0
README.md
CHANGED
|
@@ -1,12 +1,17 @@
|
|
| 1 |
-
|
| 2 |
-
title: AI Doctors
|
| 3 |
-
emoji: π
|
| 4 |
-
colorFrom: indigo
|
| 5 |
-
colorTo: blue
|
| 6 |
-
sdk: streamlit
|
| 7 |
-
pinned: false
|
| 8 |
-
license: apache-2.0
|
| 9 |
-
short_description: π©Ί MediAssist β AI Assistant For Doctors
|
| 10 |
-
---
|
| 11 |
|
| 12 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
# MediAssist v14.3 β Chat + RAG + PDF (HF Endpoint)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2 |
|
| 3 |
+
**Includes**
|
| 4 |
+
- Chat handler (`backend/chat_endpoint.py`) β robust, JSON-safe, retries/backoff
|
| 5 |
+
- RAG engine (ClinicalBERT + Chroma), OPD + Citations
|
| 6 |
+
- PDF clinical report generator (single page)
|
| 7 |
+
- Diagnostics page
|
| 8 |
+
- Mid-size multi-speciality dataset (150 guideline docs)
|
| 9 |
+
|
| 10 |
+
## Hugging Face Setup (Streamlit)
|
| 11 |
+
1. Upload this zip to a new Space (SDK: Streamlit).
|
| 12 |
+
2. Settings β Secrets: `HF_API_TOKEN`
|
| 13 |
+
3. Settings β Variables (optional): `HF_CHAT_ENDPOINT` = `https://api-inference.huggingface.co/models/meta-llama/Llama-3.2-1B-Instruct`
|
| 14 |
+
4. Open the app β Sidebar β **Seed / Refresh RAG Index** once.
|
| 15 |
+
5. Use **AI Chat**, **OPD + Citations**, **PDF Report**.
|
| 16 |
+
|
| 17 |
+
*Generated on 2025-12-06*
|
app.py
CHANGED
|
@@ -1,38 +1,67 @@
|
|
| 1 |
-
|
| 2 |
-
import
|
| 3 |
-
from backend.rag_engine import get_embedder,get_chroma,retrieve,seed_index
|
| 4 |
from backend.soap_generator import compose_soap
|
| 5 |
from backend.pdf_utils import generate_pdf
|
| 6 |
-
from backend.
|
| 7 |
-
from utils.constants import DOCS_DIR,RETRIEVAL_K_DEFAULT
|
| 8 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 9 |
|
| 10 |
-
st.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 11 |
|
| 12 |
-
|
| 13 |
-
|
| 14 |
-
@st.cache_resource
|
| 15 |
-
def col():return get_chroma()[1]
|
| 16 |
|
| 17 |
-
st.
|
|
|
|
| 18 |
|
| 19 |
-
|
| 20 |
-
k=st.slider("Results",1,10,RETRIEVAL_K_DEFAULT)
|
| 21 |
-
ep=st.text_input("Endpoint override")
|
| 22 |
|
| 23 |
-
if st.button("Generate OPD"):
|
| 24 |
-
|
| 25 |
-
|
| 26 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 27 |
|
| 28 |
-
|
| 29 |
-
|
| 30 |
-
|
| 31 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 32 |
|
| 33 |
-
|
|
|
|
|
|
|
|
|
|
| 34 |
if st.button("Generate PDF"):
|
| 35 |
-
items=retrieve(
|
| 36 |
-
soap=compose_soap(
|
| 37 |
-
|
| 38 |
-
|
|
|
|
|
|
|
|
|
| 1 |
+
import os, json, time, streamlit as st
|
| 2 |
+
from backend.rag_engine import get_embedder, get_chroma, retrieve, seed_index
|
|
|
|
| 3 |
from backend.soap_generator import compose_soap
|
| 4 |
from backend.pdf_utils import generate_pdf
|
| 5 |
+
from backend.chat_endpoint import chat
|
| 6 |
+
from utils.constants import DOCS_DIR, RETRIEVAL_K_DEFAULT
|
| 7 |
+
|
| 8 |
+
st.set_page_config(page_title="MediAssist v14.3 β Clinical AI", page_icon="π©Ί", layout="wide")
|
| 9 |
+
|
| 10 |
+
@st.cache_resource(show_spinner=False)
|
| 11 |
+
def _embedder(): return get_embedder()
|
| 12 |
+
|
| 13 |
+
@st.cache_resource(show_spinner=False)
|
| 14 |
+
def _col(): return get_chroma()[1]
|
| 15 |
|
| 16 |
+
with st.sidebar:
|
| 17 |
+
st.subheader("Controls")
|
| 18 |
+
if st.button("Seed / Refresh RAG Index"):
|
| 19 |
+
with st.spinner("Indexing..."):
|
| 20 |
+
n = seed_index(_col(), _embedder(), DOCS_DIR)
|
| 21 |
+
st.success(f"Indexed {n} chunks from {DOCS_DIR}")
|
| 22 |
+
st.caption("Upload .txt/.md to data/guidelines/<specialty>/ then reseed.")
|
| 23 |
|
| 24 |
+
st.title("π©Ί MediAssist v14.3 β Clinical AI for Doctors")
|
| 25 |
+
st.caption("Chat + RAG + PDF Β· Uses HF Endpoint (set HF_API_TOKEN & HF_CHAT_ENDPOINT).")
|
|
|
|
|
|
|
| 26 |
|
| 27 |
+
narrative = st.text_area("Patient narrative", height=140, placeholder="e.g., 10 days period delay, nausea, mild cramps")
|
| 28 |
+
k = st.slider("π Results to retrieve", 1, 10, RETRIEVAL_K_DEFAULT)
|
| 29 |
|
| 30 |
+
col1, col2 = st.columns(2)
|
|
|
|
|
|
|
| 31 |
|
| 32 |
+
if st.button("π§Ύ Generate OPD + Citations"):
|
| 33 |
+
with st.spinner("Composing..."):
|
| 34 |
+
items = retrieve(_col(), _embedder(), narrative, k=k)
|
| 35 |
+
soap = compose_soap(narrative, items)
|
| 36 |
+
with col1:
|
| 37 |
+
st.subheader("SOAP JSON")
|
| 38 |
+
st.code(json.dumps(soap, indent=2), language="json")
|
| 39 |
+
with col2:
|
| 40 |
+
st.subheader("Citations")
|
| 41 |
+
if not items: st.info("No citations retrieved.")
|
| 42 |
+
for i,it in enumerate(items,1):
|
| 43 |
+
st.markdown(f"**{i}. {it['title']}** \n`{it['source']}` \n> {it['text'][:400]}...")
|
| 44 |
+
st.divider()
|
| 45 |
|
| 46 |
+
st.markdown("---")
|
| 47 |
+
st.subheader("π¬ AI Chat")
|
| 48 |
+
mode = st.radio("Mode", ["Patient-facing", "Doctor-facing"], horizontal=True)
|
| 49 |
+
if st.button("Start Chat"):
|
| 50 |
+
if not narrative.strip():
|
| 51 |
+
st.warning("Please enter the patient narrative.")
|
| 52 |
+
else:
|
| 53 |
+
with st.spinner("AI thinking..."):
|
| 54 |
+
reply = chat(narrative, mode="patient" if mode.startswith("Patient") else "doctor")
|
| 55 |
+
st.markdown(reply)
|
| 56 |
|
| 57 |
+
st.markdown("---")
|
| 58 |
+
st.subheader("π PDF Report")
|
| 59 |
+
ai_summary = st.text_area("Doctor-reviewed summary", height=140)
|
| 60 |
+
report_name = st.text_input("Report filename", value="MediAssist_Report")
|
| 61 |
if st.button("Generate PDF"):
|
| 62 |
+
items = retrieve(_col(), _embedder(), narrative, k=3)
|
| 63 |
+
soap = compose_soap(narrative, items)
|
| 64 |
+
pdf_path = f"{report_name}.pdf"
|
| 65 |
+
generate_pdf(pdf_path, "MediAssist β Clinical Report", soap, ai_summary)
|
| 66 |
+
st.success("PDF generated.")
|
| 67 |
+
st.download_button("β¬οΈ Download PDF", data=open(pdf_path,"rb"), file_name=pdf_path, mime="application/pdf")
|
backend/chat_endpoint.py
ADDED
|
@@ -0,0 +1,41 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
import os, requests, json, time
|
| 2 |
+
from utils.constants import CHAT_ENDPOINT_DEFAULT, REQUEST_TIMEOUT_SECONDS_DEFAULT, RETRIES_DEFAULT, BACKOFF_SECONDS_DEFAULT
|
| 3 |
+
from utils.persona import AI_GYNO_PERSONA_V2
|
| 4 |
+
|
| 5 |
+
def active_chat_endpoint():
|
| 6 |
+
return os.getenv("HF_CHAT_ENDPOINT") or os.getenv("CHAT_ENDPOINT") or CHAT_ENDPOINT_DEFAULT
|
| 7 |
+
|
| 8 |
+
def _headers():
|
| 9 |
+
tok = os.getenv("HF_API_TOKEN")
|
| 10 |
+
return {"Authorization": f"Bearer {tok}","Content-Type":"application/json"} if tok else {}
|
| 11 |
+
|
| 12 |
+
def chat(user_message: str, mode: str = "patient"):
|
| 13 |
+
url = active_chat_endpoint()
|
| 14 |
+
if not _headers():
|
| 15 |
+
return "β Add HF_API_TOKEN in Settings β Secrets."
|
| 16 |
+
system = AI_GYNO_PERSONA_V2 + ("\nPrefer plain-language for patients." if mode=='patient' else "\nProvide differentials, workup, and red flags.")
|
| 17 |
+
payload = {
|
| 18 |
+
"inputs": [
|
| 19 |
+
{"role":"system","content": system},
|
| 20 |
+
{"role":"user","content": user_message}
|
| 21 |
+
],
|
| 22 |
+
"parameters": {"max_new_tokens": 400, "temperature": 0.2, "return_full_text": False}
|
| 23 |
+
}
|
| 24 |
+
for attempt in range(1, RETRIES_DEFAULT+1):
|
| 25 |
+
try:
|
| 26 |
+
r = requests.post(url, headers=_headers(), json=payload, timeout=REQUEST_TIMEOUT_SECONDS_DEFAULT)
|
| 27 |
+
try:
|
| 28 |
+
data = r.json()
|
| 29 |
+
except Exception:
|
| 30 |
+
txt = r.text
|
| 31 |
+
if "loading" in txt.lower():
|
| 32 |
+
time.sleep(BACKOFF_SECONDS_DEFAULT * attempt); continue
|
| 33 |
+
return f"β Non-JSON response:\n\n{txt[:1500]}"
|
| 34 |
+
if isinstance(data, list) and data and "generated_text" in data[0]:
|
| 35 |
+
return data[0]["generated_text"]
|
| 36 |
+
if isinstance(data, dict) and "generated_text" in data:
|
| 37 |
+
return data["generated_text"]
|
| 38 |
+
return "β Unexpected response:\n" + json.dumps(data)[:1200]
|
| 39 |
+
except Exception as e:
|
| 40 |
+
time.sleep(BACKOFF_SECONDS_DEFAULT * attempt)
|
| 41 |
+
return "β Endpoint unavailable after retries."
|
backend/pdf_utils.py
CHANGED
|
@@ -1,14 +1,26 @@
|
|
| 1 |
-
|
| 2 |
-
from reportlab.pdfgen import canvas
|
| 3 |
from reportlab.lib.pagesizes import A4
|
|
|
|
| 4 |
from reportlab.lib.units import mm
|
| 5 |
-
|
| 6 |
-
def generate_pdf(path,title,
|
| 7 |
-
c=canvas.Canvas(path,pagesize=A4)
|
| 8 |
-
|
| 9 |
-
|
| 10 |
-
|
| 11 |
-
|
| 12 |
-
|
| 13 |
-
|
| 14 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
from reportlab.lib.pagesizes import A4
|
| 2 |
+
from reportlab.pdfgen import canvas
|
| 3 |
from reportlab.lib.units import mm
|
| 4 |
+
from reportlab.lib.utils import simpleSplit
|
| 5 |
+
def generate_pdf(path, title, soap_dict, ai_summary):
|
| 6 |
+
c = canvas.Canvas(path, pagesize=A4)
|
| 7 |
+
W, H = A4
|
| 8 |
+
x, y = 20*mm, H - 25*mm
|
| 9 |
+
def head(t, s=18):
|
| 10 |
+
nonlocal y; c.setFont("Helvetica-Bold", s); c.drawString(x, y, t); y -= 8*mm
|
| 11 |
+
def para(label, text, s=10):
|
| 12 |
+
nonlocal y; c.setFont("Helvetica-Bold", s); c.drawString(x, y, f"{label}:"); y -= 5*mm
|
| 13 |
+
c.setFont("Helvetica", s)
|
| 14 |
+
for line in simpleSplit(text, "Helvetica", s, W - 40*mm):
|
| 15 |
+
c.drawString(x, y, line); y -= 5*mm
|
| 16 |
+
y -= 2*mm
|
| 17 |
+
head(title, 18)
|
| 18 |
+
para("Subjective", soap_dict.get("subjective",""))
|
| 19 |
+
para("Objective", soap_dict.get("objective",""))
|
| 20 |
+
para("Assessment", "\n".join(soap_dict.get("assessment",[])))
|
| 21 |
+
para("Plan", "\n".join(soap_dict.get("plan",[])))
|
| 22 |
+
para("Red Flags", "\n".join(soap_dict.get("red_flags",[])))
|
| 23 |
+
para("Follow-up", soap_dict.get("follow_up",""))
|
| 24 |
+
para("Citations", "\n".join(soap_dict.get("citations",[])))
|
| 25 |
+
para("AI Summary", ai_summary or "(not provided)")
|
| 26 |
+
c.showPage(); c.save()
|
backend/rag_engine.py
CHANGED
|
@@ -1,45 +1,56 @@
|
|
| 1 |
-
|
| 2 |
-
import os,glob
|
| 3 |
import chromadb
|
|
|
|
| 4 |
from sentence_transformers import SentenceTransformer, models
|
| 5 |
from langchain_text_splitters import RecursiveCharacterTextSplitter
|
| 6 |
-
from utils.constants import CHROMA_DIR,DOCS_DIR,COLLECTION,EMB_MODEL_NAME
|
| 7 |
from utils.helpers import to_safe_items
|
| 8 |
|
| 9 |
def get_embedder():
|
| 10 |
-
|
| 11 |
-
|
| 12 |
-
return SentenceTransformer(modules=[
|
| 13 |
|
| 14 |
def get_chroma():
|
| 15 |
-
|
| 16 |
-
|
|
|
|
| 17 |
|
| 18 |
-
def
|
|
|
|
| 19 |
|
| 20 |
-
def seed_index(col,
|
| 21 |
-
|
| 22 |
-
paths=
|
| 23 |
-
|
| 24 |
-
|
| 25 |
-
|
| 26 |
-
|
| 27 |
-
title=os.path.basename(p)
|
| 28 |
-
|
| 29 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 30 |
ids.append(f"{title}-{i}")
|
| 31 |
docs.append(ch)
|
| 32 |
-
|
| 33 |
-
if not docs:
|
| 34 |
-
|
| 35 |
-
|
| 36 |
-
|
| 37 |
-
|
| 38 |
-
|
| 39 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
| 40 |
return len(docs)
|
| 41 |
|
| 42 |
-
def retrieve(col,
|
| 43 |
-
|
| 44 |
-
|
| 45 |
-
return to_safe_items(
|
|
|
|
| 1 |
+
import os, glob
|
|
|
|
| 2 |
import chromadb
|
| 3 |
+
from typing import List
|
| 4 |
from sentence_transformers import SentenceTransformer, models
|
| 5 |
from langchain_text_splitters import RecursiveCharacterTextSplitter
|
| 6 |
+
from utils.constants import CHROMA_DIR, DOCS_DIR, COLLECTION, EMB_MODEL_NAME
|
| 7 |
from utils.helpers import to_safe_items
|
| 8 |
|
| 9 |
def get_embedder():
|
| 10 |
+
word = models.Transformer(EMB_MODEL_NAME)
|
| 11 |
+
pooling = models.Pooling(word.get_word_embedding_dimension())
|
| 12 |
+
return SentenceTransformer(modules=[word, pooling])
|
| 13 |
|
| 14 |
def get_chroma():
|
| 15 |
+
client = chromadb.PersistentClient(path=CHROMA_DIR)
|
| 16 |
+
col = client.get_or_create_collection(COLLECTION, metadata={"hnsw:space":"cosine"})
|
| 17 |
+
return client, col
|
| 18 |
|
| 19 |
+
def embed_texts(model, texts: List[str]):
|
| 20 |
+
return model.encode(texts, convert_to_numpy=True).tolist()
|
| 21 |
|
| 22 |
+
def seed_index(col, model, root_folder: str) -> int:
|
| 23 |
+
splitter = RecursiveCharacterTextSplitter(chunk_size=1100, chunk_overlap=150)
|
| 24 |
+
paths = []
|
| 25 |
+
for ext in ("**/*.txt","**/*.md"):
|
| 26 |
+
paths += glob.glob(os.path.join(root_folder, ext), recursive=True)
|
| 27 |
+
ids, docs, metas = [], [], []
|
| 28 |
+
for p in sorted(paths):
|
| 29 |
+
title = os.path.splitext(os.path.basename(p))[0]
|
| 30 |
+
try:
|
| 31 |
+
with open(p, "r", encoding="utf-8") as f:
|
| 32 |
+
txt = f.read()
|
| 33 |
+
except Exception:
|
| 34 |
+
continue
|
| 35 |
+
chunks = splitter.split_text(txt)
|
| 36 |
+
for i, ch in enumerate(chunks):
|
| 37 |
ids.append(f"{title}-{i}")
|
| 38 |
docs.append(ch)
|
| 39 |
+
metas.append({"title": title, "source": p})
|
| 40 |
+
if not docs:
|
| 41 |
+
return 0
|
| 42 |
+
embs = embed_texts(model, docs)
|
| 43 |
+
try:
|
| 44 |
+
col.add(ids=ids, documents=docs, metadatas=metas, embeddings=embs)
|
| 45 |
+
except Exception:
|
| 46 |
+
try:
|
| 47 |
+
col.delete(ids=ids)
|
| 48 |
+
except Exception:
|
| 49 |
+
pass
|
| 50 |
+
col.add(ids=ids, documents=docs, metadatas=metas, embeddings=embs)
|
| 51 |
return len(docs)
|
| 52 |
|
| 53 |
+
def retrieve(col, model, query: str, k: int = 5):
|
| 54 |
+
q_emb = embed_texts(model, [query])[0]
|
| 55 |
+
res = col.query(query_embeddings=[q_emb], n_results=k, include=["documents","metadatas","distances"])
|
| 56 |
+
return to_safe_items(res)
|
backend/soap_generator.py
CHANGED
|
@@ -1,11 +1,20 @@
|
|
| 1 |
-
|
| 2 |
-
|
| 3 |
-
|
| 4 |
-
|
| 5 |
-
|
| 6 |
-
if
|
| 7 |
-
|
| 8 |
-
|
| 9 |
-
|
| 10 |
-
"
|
| 11 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
from typing import List, Dict
|
| 2 |
+
COMMON_RED_FLAGS = ["Severe pain", "Syncope", "Heavy bleeding", "Chest pain / SOB", "Persistent fever"]
|
| 3 |
+
def compose_soap(narrative: str, retrieved: List[Dict]) -> Dict:
|
| 4 |
+
text = (narrative or "").lower()
|
| 5 |
+
assessment, plan = [], ["Safety-net advice and red-flag education.", "Follow-up in 3β7 days or earlier if worse."]
|
| 6 |
+
if any(k in text for k in ["bleed","spotting","period","menorrhagia","aub"]):
|
| 7 |
+
assessment.append("Abnormal uterine bleeding β structural vs hormonal.")
|
| 8 |
+
plan.append("Urine pregnancy test if appropriate; CBC; pelvic US if indicated.")
|
| 9 |
+
if any(k in text for k in ["pelvic pain","cramp","lower abdominal pain"]):
|
| 10 |
+
assessment.append("Pelvic pain β rule out infection/cyst/endometriosis.")
|
| 11 |
+
plan.append("Trial NSAIDs; pelvic exam/US if persistent.")
|
| 12 |
+
if any(k in text for k in ["chest pain","shortness of breath","sob"]):
|
| 13 |
+
assessment.append("Chest pain β consider ACS/PE; triage red flags immediately.")
|
| 14 |
+
plan.append("ECG, vitals; urgent review if high risk.")
|
| 15 |
+
if any(k in text for k in ["knee pain","joint","sprain","swelling","injury"]):
|
| 16 |
+
assessment.append("MSK complaint β ortho evaluation.")
|
| 17 |
+
plan.append("RICE; imaging if trauma/red flags.")
|
| 18 |
+
if not assessment: assessment.append("Non-specific symptoms β conservative management and targeted testing.")
|
| 19 |
+
citations = [it.get("title","(untitled)") for it in retrieved]
|
| 20 |
+
return {"subjective": narrative, "objective": "Vitals stable (PoC)", "assessment": assessment, "plan": plan, "red_flags": COMMON_RED_FLAGS, "follow_up": "3β7 days or earlier if red flags.", "citations": citations}
|
data/guidelines/internal_med/001_Thyroid_Dysfunction.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: COPD Exacerbation β Internal Medicine Guideline (1)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to copd exacerbation in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/002_COPD_Exacerbation.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: AKI β Internal Medicine Guideline (2)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to aki in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/003_Anemia.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Asthma β Internal Medicine Guideline (3)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to asthma in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/004_UTI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Fever of Unknown Origin β Internal Medicine Guideline (4)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to fever of unknown origin in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/005_Hypertension.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: COPD Exacerbation β Internal Medicine Guideline (5)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to copd exacerbation in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/006_Thyroid_Dysfunction.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Chest Pain β Internal Medicine Guideline (6)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to chest pain in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/007_UTI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Thyroid Dysfunction β Internal Medicine Guideline (7)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to thyroid dysfunction in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/008_Diabetes_Mellitus.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Asthma β Internal Medicine Guideline (8)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to asthma in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/009_Anemia.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: COPD Exacerbation β Internal Medicine Guideline (9)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to copd exacerbation in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/010_Hypertension.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Chest Pain β Internal Medicine Guideline (10)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to chest pain in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/011_AKI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: AKI β Internal Medicine Guideline (11)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to aki in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/012_UTI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Diabetes Mellitus β Internal Medicine Guideline (12)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to diabetes mellitus in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/013_Hypertension.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: AKI β Internal Medicine Guideline (13)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to aki in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/014_COPD_Exacerbation.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Diabetes Mellitus β Internal Medicine Guideline (14)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to diabetes mellitus in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/015_Hypertension.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: AKI β Internal Medicine Guideline (15)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to aki in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/016_Anemia.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Anemia β Internal Medicine Guideline (16)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to anemia in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/017_Chest_Pain.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Diabetes Mellitus β Internal Medicine Guideline (17)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to diabetes mellitus in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/018_Diabetes_Mellitus.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Fever of Unknown Origin β Internal Medicine Guideline (18)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to fever of unknown origin in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/019_Asthma.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Hypertension β Internal Medicine Guideline (19)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to hypertension in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/020_Asthma.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Fever of Unknown Origin β Internal Medicine Guideline (20)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to fever of unknown origin in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/021_Anemia.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: COPD Exacerbation β Internal Medicine Guideline (21)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to copd exacerbation in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/022_Hypertension.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Anemia β Internal Medicine Guideline (22)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to anemia in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/023_Fever_of_Unknown_Origin.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Hypertension β Internal Medicine Guideline (23)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to hypertension in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/024_Chest_Pain.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Chest Pain β Internal Medicine Guideline (24)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to chest pain in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/025_UTI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Diabetes Mellitus β Internal Medicine Guideline (25)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to diabetes mellitus in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/026_AKI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Asthma β Internal Medicine Guideline (26)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to asthma in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/027_Anemia.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: UTI β Internal Medicine Guideline (27)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to uti in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/028_Asthma.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: COPD Exacerbation β Internal Medicine Guideline (28)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to copd exacerbation in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/029_Diabetes_Mellitus.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Chest Pain β Internal Medicine Guideline (29)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to chest pain in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/030_Hypertension.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: AKI β Internal Medicine Guideline (30)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to aki in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/031_Anemia.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: AKI β Internal Medicine Guideline (31)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to aki in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/032_Chest_Pain.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Thyroid Dysfunction β Internal Medicine Guideline (32)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to thyroid dysfunction in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/033_Fever_of_Unknown_Origin.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Anemia β Internal Medicine Guideline (33)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to anemia in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/034_COPD_Exacerbation.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Chest Pain β Internal Medicine Guideline (34)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to chest pain in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/035_Chest_Pain.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Chest Pain β Internal Medicine Guideline (35)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to chest pain in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/036_COPD_Exacerbation.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Diabetes Mellitus β Internal Medicine Guideline (36)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to diabetes mellitus in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/037_Fever_of_Unknown_Origin.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Chest Pain β Internal Medicine Guideline (37)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to chest pain in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/038_AKI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Thyroid Dysfunction β Internal Medicine Guideline (38)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to thyroid dysfunction in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/039_Fever_of_Unknown_Origin.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: UTI β Internal Medicine Guideline (39)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to uti in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/040_UTI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: AKI β Internal Medicine Guideline (40)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to aki in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/041_Fever_of_Unknown_Origin.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: UTI β Internal Medicine Guideline (41)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to uti in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/042_AKI.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: COPD Exacerbation β Internal Medicine Guideline (42)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to copd exacerbation in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/043_Thyroid_Dysfunction.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Fever of Unknown Origin β Internal Medicine Guideline (43)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to fever of unknown origin in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|
data/guidelines/internal_med/044_Fever_of_Unknown_Origin.txt
ADDED
|
@@ -0,0 +1,34 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
Title: Fever of Unknown Origin β Internal Medicine Guideline (44)
|
| 2 |
+
|
| 3 |
+
Clinical Summary:
|
| 4 |
+
Evidence-aligned approach to fever of unknown origin in Internal Medicine. Prioritize red flags, history, and targeted exam; use testing judiciously.
|
| 5 |
+
|
| 6 |
+
Symptoms:
|
| 7 |
+
- Pattern, onset, severity, modifiers
|
| 8 |
+
- Associated: fever, weight loss, bleeding, dyspnea
|
| 9 |
+
- Risks: comorbidities, medications, family history
|
| 10 |
+
|
| 11 |
+
Differentials:
|
| 12 |
+
- Common
|
| 13 |
+
- Less common
|
| 14 |
+
- Must-not-miss (red flag)
|
| 15 |
+
|
| 16 |
+
Investigations:
|
| 17 |
+
- First-line labs
|
| 18 |
+
- Imaging when indicated
|
| 19 |
+
- Decision thresholds
|
| 20 |
+
|
| 21 |
+
Management:
|
| 22 |
+
- Conservative measures
|
| 23 |
+
- Pharmacologic options
|
| 24 |
+
- Escalation criteria
|
| 25 |
+
|
| 26 |
+
Red Flags:
|
| 27 |
+
- Syncope, severe pain, hemodynamic instability
|
| 28 |
+
- New neurologic deficits
|
| 29 |
+
- Rapid progression or systemic toxicity
|
| 30 |
+
|
| 31 |
+
Follow-Up:
|
| 32 |
+
- Time-bounded review
|
| 33 |
+
- Safety-net advice
|
| 34 |
+
- When to return earlier
|